National Bank of Canada’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,000
| Closed | -$6.12K | – | 2738 |
|
|
2024
Q3 | $6.12K | Sell |
6,000
-100
| -2% | -$102 | ﹤0.01% | 1982 |
|
|
2024
Q2 | $6.95K | Hold |
6,100
| – | – | ﹤0.01% | 2050 |
|
|
2024
Q1 | $6.65K | Hold |
6,100
| – | – | ﹤0.01% | 2064 |
|
|
2023
Q4 | $11K | Sell |
6,100
-27,900
| -82% | -$50.5K | ﹤0.01% | 1970 |
|
|
2023
Q3 | $53.1K | Sell |
34,000
-269,800
| -89% | -$421K | ﹤0.01% | 1573 |
|
|
2023
Q2 | $560K | Buy |
303,800
+297,700
| +4,880% | +$549K | ﹤0.01% | 1137 |
|
|
2023
Q1 | $12.7K | Hold |
6,100
| – | – | ﹤0.01% | 1936 |
|
|
2022
Q4 | $8.36K | Hold |
6,100
| – | – | ﹤0.01% | 2057 |
|
|
2022
Q3 | $6K | Hold |
6,100
| – | – | ﹤0.01% | 2136 |
|
|
2022
Q2 | $7K | Hold |
6,100
| – | – | ﹤0.01% | 2146 |
|
|
2022
Q1 | $6K | Buy |
6,100
+100
| +2% | +$98 | ﹤0.01% | 2278 |
|
|
2021
Q4 | $5K | Buy |
+6,000
| New | +$5K | ﹤0.01% | 2309 |
|